A patient at Oregon Health & Science University is the first in the world to benefit from a single stimulator implanted in the brain to effectively control two life-altering conditions: seizures caused by epilepsy and compulsive behavior caused by obsessive-compulsive disorder, or OCD.

For the first time, one electrode targets two portions of brain for dual benefit.

An OHSU patient is the first in the world to benefit from a single stimulator implanted in the brain to effectively control two life-altering conditions: seizures caused by epilepsy and compulsive behavior caused by obsessive-compulsive disorder. Ahmed Raslan, M.D., says, “It was an area that could be targeted with the same electrode.”

Data Center Dynamics reports on progress of immersion cooling company spun out of OHSU, employing technology useful in cooling data centers.

The federal health agency is awarding researchers $3.2 million to study the effects of using cannabis while receiving immunotherapy for cancer treatment, as well as whether access to marijuana helps reduce health disparities.

Doernbecher Freestyle is important to the culture of both Nike and OHSU Doernbecher, allowing doctors, nurses, hospital employees, sneaker and apparel designers and developers, and community members alike to come together to make a difference in the lives of Doernbecher Freestyle patient-designers, their families and the hospital community.

OHSU Doernbecher Children’s Hospital unveils designers of 19th annual Freestyle fundraiser.

The Week highlights pros and cons of the use of gene editing technologies in human embryos, highlighting an interview by NPR earlier this year in which Shoukhrat Mitalipov, Ph.D., says, “There are more than 10,000 single genetic mutations that collectively affect probably hundreds of millions of people around the world. We could help a lot of people.”

A patient at Oregon Health & Science University is the first in the world to benefit from a single stimulator implanted in the brain to effectively control two life-altering conditions: seizures caused by epilepsy and compulsive behavior caused by obsessive-compulsive disorder, or OCD.

OPB-Radio reports on the availability of a new therapy to prevent RSV among infants, a year after the onset of a surge of hospitalized children in Oregon. Ben Hoffman, M.D., says, “The promise of Nirsevimab is that should never, never happen again.”